Arthritis drug reduces rates of acute graft-vs-host disease after bone marrow transplant
Exciting news from a Phase 2 trial led by Leslie Kean (Dana-Farber/Boston Children’s), published Friday in the Journal of Clinical...
top of page
bottom of page